×
About 6,785 results

ALLMedicine™ Meningioma Center

Research & Reviews  2,540 results

Current knowledge on spinal meningiomas: a systematic review protocol.
https://doi.org/10.1136/bmjopen-2022-061614
BMJ Open; El-Hajj VG, Pettersson Segerlind J et. al.

Jun 24th, 2022 - Meningiomas are primary central nervous system tumours that arise from both cranial and spinal meninges. Spinal meningiomas occur less frequently than their cranial counterparts and are consequently given less attention in the literature. Therefor...

Radiographic differentiation of secretory meningiomas and WHO grade 2 meningiomas: when...
https://doi.org/10.1016/j.wneu.2022.06.061
World Neurosurgery; Trivedi MM, Momin AA et. al.

Jun 21st, 2022 - Secretory meningioma (SM) is a rare subtype of World Health Organization (WHO) grade 1 meningioma, associated with significant peritumoral brain edema (PTBE). Because of this, SM may be mistaken preoperatively to be a WHO grade 2 meningioma (G2M)....

Cabozantinib for Patients With Recurrent or Progressive Meningioma
https://clinicaltrials.gov/ct2/show/NCT05425004

Jun 21st, 2022 - A Phase II Study of Cabozantinib for Patients with Recurrent or Progressive Meningioma

The role of stereotactic radiosurgery in the management of petroclival meningioma: a sy...
https://doi.org/10.1007/s11060-022-04041-4 10.1093/neuonc/noz150 10.1007/978-3-7091-7051-9_1 10.1212/wnl.16.1.86 10.1227/01.NEU.0000311061.72626.0D 10.1016/j.wneu.2013.06.024 10.1097/COC.0b013e318271b36a 10.1016/j.ijrobp.2008.07.006 10.1159/000321187 10.3171/2010.11.JNS10326 10.1055/s-0035-1558834 10.3171/2009.8.JNS09695 10.14791/btrt.2020.8.e16 10.1159/000475763 10.1016/j.wneu.2020.04.082 10.1007/s00701-003-0123-1 10.3171/2017.7.JNS17380 10.1007/s11060-014-1470-x 10.1097/00006123-199803000-00001 10.1227/00006123-198803000-00010 10.1227/00006123-199011000-00015 10.1136/jnnp.62.4.341 10.1097/00006123-199105000-00002 10.1097/00006123-199809000-00001 10.1016/s0360-3016(02)04356-0 10.1227/01.neu.0000179924.76551.cd 10.3171/2010.3.JNS091966 10.1016/s0090-3019(02)00995-3 10.1055/s-0030-1253581 10.1016/S1042-3680(18)30688-0 10.1016/S0030-6665(20)30996-8 10.1007/978-1-4613-1081-5_38 10.1097/00006123-200106000-00010 10.1007/s00701-012-1350-0 10.1007/s00701-008-0166-4 10.1227/00006123-198307000-00003 10.2217/fon-2018-0006 10.1227/00006123-198901000-00003 10.3171/jns.1996.85.6.1013
Journal of Neuro-oncology; Wijaya JH, Arjuna YYE et. al.

Jun 19th, 2022 - Petroclival meningioma (PM) is a challenging neuro oncology case and stereotactic radiosurgery (SRS) is proposed as one treatment option. This systematic review aimed to examine the role of SRS in treating PM cases. We constructed a systematic rev...

Prevalence of autoimmunity and atopy in US adults with glioblastoma and meningioma.
https://doi.org/10.1093/neuonc/noac145
Neuro-oncology Ostrom QT, Lu D et. al.

Jun 18th, 2022 - Prevalence of autoimmunity and atopy in US adults with glioblastoma and meningioma.|2022|Ostrom QT,Lu D,Lu R,Baker MC,|

see more →

Guidelines  1 results

Stereotactic Radiosurgery for Intracranial Noncavernous Sinus Benign Meningioma: Intern...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566438
Neurosurgery Marchetti M, Sahgal A et. al.

May 29th, 2020 - Stereotactic radiosurgery (SRS) for benign intracranial meningiomas is an established treatment. To summarize the literature and provide evidence-based practice guidelines on behalf of the International Stereotactic Radiosurgery Society (ISRS). Ar...

see more →

Clinicaltrials.gov  105 results

Cabozantinib for Patients With Recurrent or Progressive Meningioma
https://clinicaltrials.gov/ct2/show/NCT05425004

Jun 21st, 2022 - A Phase II Study of Cabozantinib for Patients with Recurrent or Progressive Meningioma

Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas
https://clinicaltrials.gov/ct2/show/NCT05130866

Jun 15th, 2022 - This is a parallel-group, two-staged, Phase 2/3, randomized, multi-center study to investigate the efficacy and safety of REC-2282 in patients with progressive NF2 mutated meningiomas, with either NF2 disease-related meningioma or recurrent sporad...

AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas
https://clinicaltrials.gov/ct2/show/NCT02831257

Jun 13th, 2022 - This research study is a Phase II clinical trial. Phase II clinical trials test the safety and effectiveness of an investigational intervention to learn whether the intervention works in treating a specific disease. "Investigational" means that th...

Embolization for Meningioma
https://clinicaltrials.gov/ct2/show/NCT05416567

Jun 13th, 2022 - The natural course for meningioma suggests that a majority will grow over time. Treatment is usually indicated in growing or symptomatic meningiomas. Surgery is usually primary treatment, but there is a significant risk of adverse effects. Stereot...

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2
https://clinicaltrials.gov/ct2/show/NCT04374305

Jun 10th, 2022 - This research study is a Phase II clinical trial. Phase II clinical trials test the safety and effectiveness of investigational drugs to learn whether the drug(s) works in treating a specific disease. The Master study is intended to enroll partici...

see more →

News  60 results

Brain Tumors Exact Higher Mortality Toll in Men Than Women
https://www.medscape.com/viewarticle/968594

Feb 15th, 2022 - New research shows that men in their 20s and 30s have worse survival from many different types of brain tumors than women of the same age. And, researchers say, it’s not exactly clear why. Differences in treatment may mediate some of the associati...

GI Cancer and Obesity: Fighting One Means Addressing the Other
https://www.medscape.com/viewarticle/959973

Oct 6th, 2021 - By 2030, it is projected that most Americans will be overweight, and of those, nearly 50% of adults will be obese. Although the majority of Americans are aware that obesity can have adverse health consequences, survey findings show that few are aw...

Increased Risk of Meningioma With Cyproterone Acetate Use
https://www.medscape.com/viewarticle/945218

Feb 3rd, 2021 - New details confirm an increased risk of developing intracranial meningiomas after prolonged use of the hormonal product cyproterone acetate. Cyproterone acetate is a synthetic progestogen and potent anti-androgen that has been used in the treatme...

Meningioma May Be Tied to Dental X-Rays
https://www.onclive.com/view/meningioma-may-be-tied-to-dental-x-rays

Dec 5th, 2020 - Elizabeth B. Claus, MD New data suggest that dental x-rays obtained frequently at a young age may boost the risk of intracranial meningioma. Although dental x-rays are an important tool in well selected patients, efforts to moderate exposure to ...

Direct Targeting of RET Aberrations Moves Closer to the Clinic
https://www.onclive.com/view/direct-targeting-of-ret-aberrations-moves-closer-to-the-clinic

Dec 5th, 2020 - Alexander Drilon, MD Research on the proto-oncogene RET has accelerated exponentially since 1985, when Masahide Takahashi, MD, PhD, and colleagues first reported a fusion rearrangement in lymphoma DNA.1 Early progress was slow. Other investigator...

see more →

Patient Education  8 results see all →